Serotonin and Depression: What the Evidence Does and Does Not Show

Evidence checked 2026-09-24 · 7.8318181818182 min read

Updated 24 September 2026. Educational information about research and treatment decisions, not an individual prescribing recommendation.

Why the chemical-imbalance explanation is incomplete

The phrase chemical imbalance is often understood as a measurable shortage that a medicine directly replaces. That is not how depression is ordinarily diagnosed. A clinician assesses symptoms, their course, functioning, safety and other possible explanations.

A biological contribution does not have to take the form of one chemical being consistently low in everyone. Equally, saying that biology is complex should not become an excuse for making an unsupported claim about your particular brain.

Ask what a proposed explanation actually means. Is it an established finding about you, a general hypothesis or a simplified way of describing a medicine’s action? Keeping those categories separate makes discussions about treatment more accurate.

What serotonin research investigates

Serotonin is involved in signaling between cells, and researchers study different aspects of that system. Measurements of receptors, transporters or substances in body fluids do not all answer the same question.

An association with depression would also need interpretation. A difference could relate to the illness, treatment exposure or other factors, and an association alone would not establish a cause. Research findings in groups do not automatically become a diagnostic test for one person.

This is why a headline about a serotonin study may be much more confident than the result justifies. Look for the actual question, the population studied and whether the research concerns causation, diagnosis or treatment response.

What the widely discussed umbrella review found

A systematic umbrella review by Moncrieff and colleagues, first published online in 2022, examined several areas of serotonin research. Its authors concluded that the reviewed evidence did not consistently support depression being caused by reduced serotonin concentration or activity.

The review synthesized existing research rather than testing each reader’s serotonin level. Its scope and conclusions should not be converted into a claim that every biological theory of depression has been disproved or that no treatment affecting serotonin can help.

The publication date also matters. Later discussion or republication of a study is not necessarily a new experiment. When reading a new headline, check whether it reports new data, a review or commentary about earlier work.

Why researchers disagree about the interpretation

A 2023 response by Jauhar and colleagues challenged aspects of the umbrella review’s methods and interpretation, arguing that evidence still implicates serotonin in depression. This disagreement concerns how to interpret a complex research field, not a validated test that can classify your depression today.

A fair account should acknowledge both the challenge to a simple deficiency story and the disagreement about serotonin’s broader role. Neither position justifies pretending that a single mechanism has been established for every person.

Check study methods and declared interests rather than deciding credibility from confidence alone. Conflicts of interest deserve scrutiny, but they do not by themselves determine whether a particular argument or result is correct.

Cause, mechanism and treatment benefit are separate questions

A treatment can affect a biological process without proving that a deficiency in that process caused the condition. Conversely, uncertainty about the original cause does not establish that treatment has no effect. These are logical distinctions, not a recommendation for or against medication.

For treatment decisions, the relevant evidence includes outcomes in clinical trials, adverse effects, individual history and preferences. A plausible mechanism is not enough to demonstrate benefit, and a clinical benefit does not explain every step through which it occurred.

Ask a prescriber to discuss both the evidence and its limits. You should not have to accept an oversimplified biological story to participate in a sensible treatment discussion.

What antidepressant trials can tell us

A 2018 network meta-analysis by Cipriani and colleagues examined acute treatment trials in adults with major depressive disorder. The antidepressants studied showed average efficacy advantages over placebo, with differences in acceptability and uncertainty in the evidence.

That finding does not guarantee that a particular medicine will help a particular person. It also does not settle every question about long-term treatment, withdrawal or which option best fits someone with several health conditions.

A useful interpretation is neither that medicines always work nor that they never work. Discuss the expected benefit, possible harms, alternatives and review arrangements in your own circumstances.

What an SSRI prescription does and does not mean

Selective serotonin reuptake inhibitors, or SSRIs, act on serotonin reuptake. A prescription does not mean that a blood test has established low brain serotonin, and the name of the drug class does not provide a complete account of how improvement occurs.

The NHS sertraline information explains the use and practical safety considerations for one SSRI. Individual drugs have different considerations, so general information should be followed by advice specific to the medicine prescribed.

Ask which symptoms treatment is intended to address, how long the initial monitored trial is expected to last and when you should contact the prescriber sooner. Our SSRI guide and antidepressant overview provide further questions.

A serotonin blood test is not a depression test

Blood serotonin testing exists for other medical purposes. MedlinePlus describes its use in evaluating suspected carcinoid syndrome, not as a routine way to diagnose depression or select an antidepressant.

A result from blood or another body sample should not be treated as a direct reading of serotonin activity throughout the brain. Ask what a proposed test has been validated to diagnose and how the result would change care.

Be cautious when a commercial service promises to reveal your personal chemical imbalance and immediately sells a matching supplement. A measurable substance is not automatically a useful clinical marker for the problem being advertised.

Do not replace one single-cause story with another

Rejecting an overly simple serotonin explanation does not prove that depression is always caused by stress, trauma, diet or a particular life event. Different histories and contributors need assessment.

Physical health, sleep, treatment effects and social circumstances can all be relevant without providing a universal explanation. Our medical-contributors guide explains why assessment should consider more than one possibility.

The practical goal is to identify treatable needs and an appropriate plan. You do not need to find one complete theory of depression before receiving help.

Food, supplements and serotonin-boosting claims

A claim that a food or product affects a biochemical pathway is not the same as evidence that it treats depression. Ask whether the claimed outcome was measured in people with the relevant condition, not simply inferred from laboratory findings.

Tell your pharmacist or prescriber about supplements and nonprescription products before combining them with medication. Products marketed as natural are not automatically free of interactions or adverse effects.

This article does not recommend a serotonin-boosting supplement regimen. Nourishment and practical help with eating can support health, but an expensive product should not replace clinical assessment or established treatment.

Serotonin syndrome is a different clinical issue

Serotonin syndrome is a potentially serious reaction associated with certain medicines or combinations that affect serotonin. It is not evidence that depression was originally caused by low serotonin.

New agitation or confusion with fever, marked tremor, muscle stiffness or other concerning symptoms after a medication or substance change needs urgent medical advice. Severe symptoms or rapid deterioration warrant emergency help.

Bring the medicine and product list to the assessment. Do not try to diagnose the reaction, counteract it with another substance or wait for an online reply when someone is seriously unwell.

Preparing a medication review

Describe what improved, what did not and what unwanted effects appeared. Include changes in sleep, appetite, sexual functioning, emotional experience and everyday activities. A balanced account is more useful than deciding beforehand that the medicine is either essential or useless.

Ask what options are available and how each would be monitored. These may involve continuing treatment, a clinician-led change, psychological therapy or attention to another contributor. The right choice depends on the assessment.

Our side-effects guide explains how to organize the discussion. Report worsening safety or marked activation promptly instead of waiting for a routine appointment.

Stopping treatment requires planning, not a reaction to a headline

Do not abruptly stop an antidepressant because an article questions a mechanism. Withdrawal and recurrence of symptoms can complicate the situation, and the appropriate stopping plan depends on the medicine and your history.

Equally, you can ask about reducing or stopping treatment without being dismissed. The review should include your reasons, previous experiences and the support needed if symptoms change.

Our stopping-antidepressants guide covers questions to raise with the prescriber. A scientific disagreement should lead to a better-informed conversation, not an unsupported medication experiment.

Questions that make research headlines more useful

Ask whether the study concerns a cause, an association, a diagnostic test or a treatment outcome. Then check who was studied, what was measured and whether the conclusion applies to your situation.

Consider whether the headline leaves out limitations or treats disagreement as proof that all care is unreliable. Medical decisions often need to be made with incomplete knowledge, but uncertainty should be explained rather than hidden.

You can bring a paper to an appointment and ask what, if anything, it changes about your plan. The answer may be that it improves the explanation without changing the treatment that is helping you.

Frequently asked questions

Does this mean depression is not a real illness?

No. Uncertainty about a single mechanism does not invalidate symptoms, impairment or the need for care. Diagnosis is based on the clinical pattern, not a serotonin measurement.

Does improvement on an SSRI prove I had low serotonin?

No. Treatment response is important information but does not establish the original cause or a measured deficiency.

Must I choose between therapy and medication?

Not necessarily. They may be alternatives or used together, depending on need and preference. Discuss a plan that includes benefits, limitations and follow-up.

When help is urgent

Immediate danger, inability to stay safe or a severe medication reaction requires urgent help. Contact local emergency services when the situation is life-threatening. For other urgent mental-health concerns, use your treating service or appropriate local crisis support; see crisis information.